What is Vasthera?
A start-up pharmaceutical company that develops the first-in-class
synthetic therapeutics targeting the vascular hyperplasia.
- Developing the drug candidates for pulmonary arterial hypertension treatment
- Expanding application of drug candidates to other arterial disease, i.e. restenosis
- Providing a platform technology for the peroxide-based redox signaling network
Patent Status
- Pharmaceutical composition for preventing or treating restenosis comprising epidithiodioxopiperazine compound or its derivative; or pharmaceutically acceptable salt thereof, US 9,765,090
- Epidithiodioxopiperazine compound or its derivatives, and the use thereof, KOREA 10-1633975
- Epidithiodioxopiperazine compound or its derivatives, and the use thereof, CHINA ZL 201480019817.1
